Close

Analyst Ratings for Sage Therapeutics (SAGE) [Sells]

SAGE Rating Summary

SAGE Price Target Summary

* Over Last 12-Mos
  |   Expand Research on SAGE
Overall Rating: NEUTRAL   Rating Trend: Down   Avg. $ Target: $21.60 (+65.6%) * Over Last 12-Mos
Rating Score: 2.4 / 10   Percentile Rank: 18%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
4/17/2024 BofA Securities Tazeen Ahmad Downgrade Underperform
(Neutral)
14.00
(24.00)
15.63
(13.04)
-16.57% Details